BUENA, N.J., May 3, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Deutsche Bank 42nd Annual Health Care Conference. The Conference is taking place on May 3-4, 2017 at the InterContinental Boston Hotel, Boston, MA.
Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will present on Wednesday, May 3, 2017 at 12:50 p.m. ET.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
|
Contact: |
Jenniffer Collins |
|
Teligent, Inc. | |
|
(856) 697-4379 | |
SOURCE Teligent, Inc.